Teaming Up Two Biotech Winners to Fight Cancer: CRISPR and CAR T

by admin | Jan 20, 2023 | News & Opinions

by William A. Haseltine – Forbes Here we describe early clinical trial results on combination CRISPR and CAR T therapy, a sequel to an earlier, introductory piece. Other alternative CAR T designs include mRNA vectors to create temporary CAR T cells and the use...

The future of replacement organs is (quite possibly) here: Robust human intestinal organoids created in a lab

by admin | Jan 19, 2023 | News & Opinions

by Tokyo Medical and Dental University – Phys.org Growing miniature organ-like tissues in the lab is already within our reach. Now, researchers from Japan have developed a new approach that enables intestinal mini-organs to be grown more easily and efficiently...

MS patients could be offered stem cell transplants as a first-line treatment in new world-first trial

by admin | Jan 18, 2023 | News & Opinions

A world-first trial is investigating if stem cell transplantation could be used in patients with aggressive multiple sclerosis (MS) as a first-line treatment. By University of Sheffield The study launched by the University of Sheffield and Sheffield Teaching Hospitals...

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

by admin | Jan 17, 2023 | News & Opinions

CIRM grant will fund novel gene therapy aiming for one-time, lifelong treatment of Friedreich’s ataxia, a progressive neuromuscular disorder; second CIRM grant will advance efforts to leverage UC San Diego research on another rare disease By Scott LaFee – UC San...

Scientists identify neurons that restore walking after paralysis

by admin | Jan 13, 2023 | News & Opinions

By EPFL News A new study by scientists at the .NeuroRestore research center has identified the type of neuron that is activated and remodeled by spinal cord stimulation, allowing patients to stand up, walk and rebuild their muscles – thus improving their quality of...